Clinical Report: Can GDMT Be Safely Stopped After AF Ablation?
Overview
This study investigates the safety of discontinuing guideline-directed medical therapy (GDMT) in patients with atrial fibrillation (AF) after successful catheter ablation. Heart failure deterioration was observed in a subset of patients who stopped GDMT.
Background
Atrial fibrillation is a prevalent condition that can lead to heart failure and other complications. Catheter ablation has emerged as a treatment option that may restore cardiac function in patients with AF-mediated cardiomyopathy.
Data Highlights
| Group | Heart Failure Deterioration | NT-proBNP Levels | Adverse Events |
|---|---|---|---|
| GDMT Withdrawal | 3 of 23 (13%) | Less decline | 0 |
| GDMT Continuation | 0 of 24 (0%) | More decline | 5 of 24 (21%) |
Key Findings
- Heart failure deterioration occurred in 13% of patients who withdrew GDMT.
- No heart failure deterioration was observed in the GDMT continuation group.
- NT-proBNP levels declined more significantly in patients who continued GDMT.
- Adverse drug events were reported only in the GDMT continuation group (21%).
- Atrial tachyarrhythmia recurrence rates were equal in both groups (13%).
Clinical Implications
Continuous monitoring and assessment of cardiac function are essential in this patient population.
Conclusion
Further larger studies with longer follow-up are needed to determine whether GDMT can be safely discontinued in this population.
Related Resources & Content
- Li S, et al., JAMA Network Open, 2023 -- Can GDMT Be Safely Stopped After AF Ablation?
- Obesity Surgery — Safety Framework for Gastric Mucosal Ablation (GMA) Using Hybrid Argon Plasma Coagulation (hAPC): International Expert Consensus
- Clinical Research in Cardiology — Evaluation of Arctic Front Advance Pro versus POLARx Cryoballoons in Atrial Fibrillation Ablation: An Intraprocedural Examination
- Clinical Research in Cardiology — Assessing Cerebral Oxygen Levels During Ventricular Tachycardia Ablation in Patients with Structural Heart Conditions
- Clinical Research in Cardiology — Long-term Results Following Multiple Ventricular Tachycardia Ablations in Patients with Non-Ischemic Cardiomyopathy
- 2024 ESC Guidelines for the management of atrial fibrillation
- Catheter Ablation for Atrial Fibrillation with Heart Failure
- Withdrawal of heart failure therapy after atrial fibrillation rhythm control with ejection fraction normalization: the WITHDRAW-AF trial - PMC
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
